Chronic Spine Pain: Whether from disc degeneration, facet joint disease, or muscular dysfunction, peptides can address the underlying tissue pathology contributing to persistent back and neck pain
Based on these data, the FDA approved tesamorelin (marketed as EGRIFTA) for the reduction of excess abdominal fat in HIVassociated lipodystrophy, not as a general weightloss drug for the wider population. Tesamorelin Risks and Considerations Like all hormonemodulating therapies, tesamorelin carries potential risks, including fluid retention, joint pain, injectionsite reactions, and effects on glucose metabolism in susceptible patients
Regulations vary by region and discipline: Many equestrian sports organizations prohibit peptide use in competition
GHK-Cu boosts collagen and skin renewal, BPC-157 supports healing and blood vessel growth, and TB-500 helps cells move to where repair is needed